-
Albà MM, Das R, Orengo CA, Kellam P (2001) Genomewide function conservation and phylogeny in the Herpesviridae. Genome Res 11:43–54
doi: 10.1101/gr.149801
-
Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR (2006) Lambda interferon (IFN-λ), a type Ⅲ IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80:4501–4509
doi: 10.1128/JVI.80.9.4501-4509.2006
-
Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H (2008) An important role for type Ⅲ interferon (IFN-λ/IL-28) in TLR-induced antiviral activity. J Immunol 180:2474–2485
doi: 10.4049/jimmunol.180.4.2474
-
Arslan M, Yang X, Santhakumar D, Liu X, Hu X, Munir M, Li Y, Zhang Z (2019) Dynamic expression of interferon lambda regulated genes in primary fibroblasts and immune organs of the chicken. Genes 10:145
doi: 10.3390/genes10020145
-
Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (2007) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge
-
Berry R, Watson GM, Jonjic S, Degli-Esposti MA, Rossjohn J (2020) Modulation of innate and adaptive immunity by cytomegaloviruses. Nat Rev Immunol 20:113–127
doi: 10.1038/s41577-019-0225-5
-
Bibert S, Wojtowicz A, Taffé P, Manuel O, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M (2014) The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. Aids 28:1885–1889
doi: 10.1097/QAD.0000000000000379
-
Bilichodmath S, Nair SK, Bilichodmath R, Mangalekar SB (2018) mRNA expression of IFN-λs in the gingival tissue of patients with chronic or aggressive periodontitis: a polymerase chain reaction study. J Periodontol 89:867–874
doi: 10.1002/JPER.17-0349
-
Bin L, Li X, Richers B, Streib JE, Hu JW, Taylor P, Leung DY (2018) Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum. J Allergy Clin Immunol 141(2085–2093):e2081
doi: 10.1016/j.jaci.2018.01.001
-
Blumer T, Coto-Llerena M, Duong FH, Heim MH (2017) SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo. J Biol Chem 292:17928–17938
doi: 10.1074/jbc.M117.788877
-
Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte J-M, Diebold J, Diepolder H, Adler B, Auernhammer CJ (2005) IL-28A and IL-29 Mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic expression. Am J Physiol Gastrointest Liver Physiol 289:960–968
doi: 10.1152/ajpgi.00126.2005
-
Bravo D, Solano C, Giménez E, Remigia MJ, Corrales I, Amat P, Navarro D (2014) Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients. J Med Virol 86:838–844
doi: 10.1002/jmv.23865
-
Chen S, Zhang W, Zhou Q, Wang A, Sun L, Wang M, Jia R, Zhu D, Liu M, Sun K (2017) Cross-species antiviral activity of goose interferon lambda against duck plague virus is related to its positive self-regulatory feedback loop. J Gen Virol 98:1455–1466
doi: 10.1099/jgv.0.000788
-
Costa AS, Agostini S, Guerini FR, Mancuso R, Zanzottera M, Ripamonti E, Racca V, Nemni R, Clerici M (2017) Modulation of immune responses to herpes simplex virus type 1 by IFNL3 and IRF7 polymorphisms: a study in Alzheimer's disease. J Alzheimer's Dis 60:1055–1063
doi: 10.3233/JAD-170520
-
Dağ F, Dölken L, Holzki J, Drabig A, Weingärtner A, Schwerk J, Lienenklaus S, Conte I, Geffers R, Davenport C (2014) Reversible silencing of cytomegalovirus genomes by type i interferon governs virus latency. PLoS Pathog 10:e1003962
doi: 10.1371/journal.ppat.1003962
-
Danastas K, Miranda-Saksena M, Cunningham AL (2020) Herpes Simplex Virus Type 1 Interactions with the Interferon System. Int J Mol Sci 21:5150
doi: 10.3390/ijms21145150
-
De Pelsmaeker S, Romero N, Vitale M, Favoreel HW (2018) Herpesvirus evasion of natural killer cells. J Virol 92:e2105–e2117
-
De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW (2010) Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PloS one 5:e13076
doi: 10.1371/journal.pone.0013076
-
Ding S, Khoury-Hanold W, Iwasaki A, Robek MD (2014) Epigenetic reprogramming of the type Ⅲ interferon response potentiates antiviral activity and suppresses tumor growth. PLoS Biol 12:e1001758
doi: 10.1371/journal.pbio.1001758
-
Donnelly RP, Kotenko SV (2010) Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res 30:555–564
doi: 10.1089/jir.2010.0078
-
Egli A, Levin A, Santer DM, Joyce M, O'Shea D, Thomas BS, Lisboa LF, Barakat K, Bhat R, Fischer KP (2014) Immunomodulatory function of interleukin 28B during primary infection with cytomegalovirus. J Infect Dis 210:717–727
doi: 10.1093/infdis/jiu144
-
Enquist LW, Leib DA (2017) Intrinsic and innate defenses of neurons: Detente with the herpesviruses. J Virol 91
-
Fan W, Xie S, Zhao X, Li N, Chang C, Li L, Yu G, Chi X, Pan Y, Niu J (2016) IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis c through long-term induction of USP18. J Gen Virol 97:2210–2220
doi: 10.1099/jgv.0.000522
-
Fernández-Ruiz M, Corrales I, Amat P, González E, Andrés A, Navarro D, Aguado J (2015) Influence of age and HLA Alleles on the CMV-specific cell-mediated immunity among CMV-seropositive kidney transplant candidates. Am J Transplant Off J Am Soc Transplante Am Soc Transplant Surg 15:2525–2526
doi: 10.1111/ajt.13370
-
Fuld S, Cunningham C, Klucher K, Davison AJ, Blackbourn DJ (2006) Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80:3092–3097
doi: 10.1128/JVI.80.6.3092-3097.2006
-
García-Sastre A (2017) Ten strategies of interferon evasion by viruses. Cell Host Microbe 22:176–184
doi: 10.1016/j.chom.2017.07.012
-
Gimeno Brias S, Marsden M, Forbester J, Clement M, Brandt C, Harcourt K, Kane L, Chapman L, Clare S, Humphreys IR (2018) Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection. PLoS ONE 13:e0197596
doi: 10.1371/journal.pone.0197596
-
Gonzalez-Perez AC, Stempel M, Chan B, Brinkmann MM (2020) One step ahead: herpesviruses Light the Way to Understanding Interferon-Stimulated Genes (ISGs). Front Microbiol 11:124
doi: 10.3389/fmicb.2020.00124
-
Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, Pica F, Gonzalez O, Friedel CC, Barry G, Martin K (2013) A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog 9:e1003514
doi: 10.1371/journal.ppat.1003514
-
Grinde B (2013) Herpesviruses: latency and reactivation–viral strategies and host response. J Oral Microbiol 5:22766
doi: 10.3402/jom.v5i0.22766
-
Huang M, Jiang J-D, Peng Z (2014) Recent advances in the anti-HCV mechanisms of interferon. Acta Pharmaceutica Sinica B 4:241–247
doi: 10.1016/j.apsb.2014.06.010
-
Iversen MB, Ank N, Melchjorsen J, Paludan SR (2010) Expression of type Ⅲ interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-κB than type Ⅰ IFNs. J Virol 84:4579–4586
doi: 10.1128/JVI.02591-09
-
Jacobs S, Zeippen C, Wavreil F, Gillet L, Michiels T (2019) IFN-λ Decreases Murid Herpesvirus-4 infection of the olfactory epithelium but fails to prevent virus reactivation in the vaginal mucosa. Viruses 11:757
doi: 10.3390/v11080757
-
Jahanban-Esfahlan R, Seidi K, Majidinia M, Karimian A, Yousefi B, Nabavi SM, Astani A, Berindan-Neagoe I, Gulei D, Fallarino F (2019) Toll-like receptors as novel therapeutic targets for herpes simplex virus infection. Rev Med Virol 29:e2048
doi: 10.1002/rmv.2048
-
Jayanthi D, Faizuddin M, Noor Ahamadi H (2017) Association of interferon lambda-1 with herpes simplex viruses-1 and-2, Epstein-Barr virus, and human cytomegalovirus in chronic periodontitis. J Investig Clin Dent 8:e12200
doi: 10.1111/jicd.12200
-
Johnston C, Gottlieb SL, Wald A (2016) Status of vaccine research and development of vaccines for herpes simplex virus. Vaccine 34:2948–2952
doi: 10.1016/j.vaccine.2015.12.076
-
Jones C (2019) Bovine herpesvirus 1 counteracts immune responses and immune-surveillance to enhance pathogenesis and virus transmission. Front Immunol 10:1008
doi: 10.3389/fimmu.2019.01008
-
Karpala AJ, Morris KR, Broadway MM, McWaters PG, O'Neil TE, Goossens KE, Lowenthal JW, Bean AG (2008) Molecular cloning, expression, and characterization of chicken IFN-λ. J Interferon Cytokine Res 28:341–350
doi: 10.1089/jir.2007.0117
-
Kim J-A, Park S-K, Seo S-W, Lee C-H, Shin OS (2017) STING is involved in antiviral immune response against VZV infection via the induction of type Ⅰ and Ⅲ IFN pathways. J Investig Dermatol 137:2101–2109
doi: 10.1016/j.jid.2017.03.041
-
Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003) IFN-λs mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex. Nat Immunol 4:69–77
-
Koyuncu OO, MacGibeny MA, Enquist LW (2018) Latent versus productive infection: The alpha herpesvirus switch. Future Virol 13:431–443
doi: 10.2217/fvl-2018-0023
-
Kuhs KAL, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters MG, Plankey M, Sharp GB, Strickler HD (2015) Interferon lambda 4 genotype is not associated with recurrence of oral or genital herpes. PLoS ONE 10:e0138827
doi: 10.1371/journal.pone.0138827
-
La Rosa F, Agostini S, Bianchi A, Nemni R, Piancone F, Marventano I, Mancuso R, Saresella M, Clerici M (2019) Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients. J Translat Med 17:286
doi: 10.1186/s12967-019-2034-9
-
Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, Nischalke HD, Nattermann J, Oldenburg J, Sauerbruch T, Spengler U (2011) Interferon-lambda serum levels in hepatitis C. J Hepatol 54:859–865
doi: 10.1016/j.jhep.2010.08.020
-
Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, Freudenberg MA, Davey GM, Vremec D, Kallies A (2010) Mouse CD8α+DCs and human BDCA3+DCs are major producers of IFN-λ in response to poly IC. J Exp Med 207:2703–2717
doi: 10.1084/jem.20092720
-
Li J, Hu S, Zhou L, Ye L, Wang X, Ho J, Ho W (2011) Interferon lambda inhibits herpes simplex virus type Ⅰ infection of human astrocytes and neurons. Glia 59:58–67
doi: 10.1002/glia.21076
-
Li J, Ye L, Wang X, Hu S, Ho W (2012) Induction of interferon-λ contributes to toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes. J Neurosci Res 90:399–406
doi: 10.1002/jnr.22758
-
Li Z, Lu X, Zhu Y, Cheng P, Liu S, Zhang Y, Tang J, Yang S, Zhou L (2017) Lambda-interferons inhibit herpes simplex virus type 2 replication in human cervical epithelial cells through activation of JAK/STAT pathway. Jpn J Infect Dis JJID 2016:2465
doi: 10.7883/yoken.JJID.2016.465
-
Linderman JA, Kobayashi M, Rayannavar V, Fak JJ, Darnell RB, Chao MV, Wilson AC, Mohr I (2017) Immune escape via a transient gene expression program enables productive replication of a latent pathogen. Cell Rep 18:1312–1323
doi: 10.1016/j.celrep.2017.01.017
-
Liu F, Liu C, Hu X, Shang Y, Wu L (2017) MicroRNA-21: a positive regulator for optimal production of type Ⅰ and type Ⅲ interferon by plasmacytoid dendritic cells. Front Immunol 8:947
doi: 10.3389/fimmu.2017.00947
-
Liu Q, Rao Y, Tian M, Zhang S, Feng P (2019) Modulation of innate immune signaling pathways by herpesviruses. Viruses 11:572
doi: 10.3390/v11060572
-
Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, Newman LM (2015) Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE 10:e0140765
doi: 10.1371/journal.pone.0140765
-
Lopušná K, Režuchová I, Kabat P, Kúdelová M (2014) Interferon lambda induces antiviral response to herpes simplex virus 1 infection. Acta Virol 58:325–332
doi: 10.4149/av_2014_03_325
-
Lopušná K, Benkóczka T, Lupták J, Matúšková R, Lukáčiková L', Ovečková I, Režuchová I (2016) Murine gammaherpesvirus targets type Ⅰ IFN receptor but not type Ⅲ IFN receptor early in infection. Cytokine 83:158–170
doi: 10.1016/j.cyto.2016.04.013
-
Manuel O, Wójtowicz A, Bibert S, Mueller NJ, Van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C (2015) Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 211:906–914
doi: 10.1093/infdis/jiu557
-
Megjugorac NJ, Gallagher GE, Gallagher G (2009) Modulation of human plasmacytoid DC function by IFN-λ1 (IL-29). J Leukoc Biol 86:1359–1363
doi: 10.1189/jlb.0509347
-
Megjugorac NJ, Gallagher GE, Gallagher G (2010) IL-4 enhances IFN-λ1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra. Blood J Am Soc Hematol 115:4185–4190
doi: 10.1182/blood-2009-09-246157
-
Melchjorsen J, Siren J, Julkunen I, Paludan SR, Matikainen S (2006) Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-κB and IRF-3. J Gen Virol 87:1099–1108
doi: 10.1099/vir.0.81541-0
-
Melchjorsen J, Rintahaka J, Søby S, Horan KA, Poltajainen A, Østergaard L, Paludan SR, Matikainen S (2010) Early innate recognition of herpes simplex virus in human primary macrophages is mediated via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase Ⅲ-independent pathways. J Virol 84:11350–11358
doi: 10.1128/JVI.01106-10
-
Murray MJ, Peters NE, Reeves MB (2018) Navigating the host cell response during entry into sites of latent cytomegalovirus infection. Pathogens 7:30
doi: 10.3390/pathogens7010030
-
Nordström I, Eriksson K (2012) HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9. PLoS ONE 7:e38683
doi: 10.1371/journal.pone.0038683
-
Odendall C, Dixit E, Stavru F, Bierne H, Franz KM, Durbin AF, Boulant S, Gehrke L, Cossart P, Kagan JC (2014) Diverse intracellular pathogens activate type Ⅲ interferon expression from peroxisomes. Nat Immunol 15:717
doi: 10.1038/ni.2915
-
Onabajo OO, Muchmore B, Prokunina-Olsson L (2019) The IFN-λ4 conundrum: when a good interferon goes bad. J Interferon Cytokine Res 39:636–641
doi: 10.1089/jir.2019.0044
-
Paquin A, Onabajo OO, Tang W, Prokunina-Olsson L (2016) Comparative functional analysis of 12 mammalian IFN-λ4 orthologs. J Interferon Cytokine Res 36:30–36
doi: 10.1089/jir.2015.0096
-
Pica F, Volpi A, Gaziano R, Garaci E (2010) Interferon-λ in immunocompetent individuals with a history of recurrent herpes labialis. Antiviral Therapy 15:737
doi: 10.3851/IMP1610
-
Pontejo SM, Murphy PM, Pease JE (2018) Chemokine subversion by human herpesviruses. J Innate Immun 10:465–478
doi: 10.1159/000492161
-
Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164–171
doi: 10.1038/ng.2521
-
Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J (2003) IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R. Nat Immunol 4:63–68
doi: 10.1038/ni873
-
Song R, Koyuncu OO, Greco TM, Diner BA, Cristea IM, Enquist LW (2016) Two modes of the axonal interferon response limit alphaherpesvirus neuroinvasion. mBio 7:e02145–15
doi: 10.1128/mBio.02145-15
-
Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T (2013) Antiviral type ⅰ and type ⅲ interferon responses in the central nervous system. Viruses 5:834–857
doi: 10.3390/v5030834
-
Steed AL, Barton ES, Tibbetts SA, Popkin DL, Lutzke ML, Rochford R, Virgin HW (2006) Gamma interferon blocks gammaherpesvirus reactivation from latency. J Virol 80:192–200
doi: 10.1128/JVI.80.1.192-200.2006
-
Su C, Zhan G, Zheng C (2016) Evasion of host antiviral innate immunity by HSV-1, an update. Virol J 13:1–9
doi: 10.1186/s12985-015-0456-4
-
Sun C, Luecke S, Bodda C, Jønsson KL, Cai Y, Zhang B-C, Jensen SB, Nordentoft I, Jensen JM, Jakobsen MR (2019) Cellular requirements for sensing and elimination of incoming HSV-1 DNA and capsids. J Interferon Cytokine Res 39:191–204
doi: 10.1089/jir.2018.0141
-
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'hUigin C, Kidd J, Kidd K, Khakoo SI, Alexander G (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798–801
doi: 10.1038/nature08463
-
Thomson SJ, Goh FG, Banks H, Krausgruber T, Kotenko SV, Foxwell BM, Udalova IA (2009) The role of transposable elements in the regulation of IFN-λ1 gene expression. Proc Natl Acad Sci 106:11564–11569
doi: 10.1073/pnas.0904477106
-
Tognarelli EI, Palomino TF, Corrales N, Bueno SM, Kalergis AM, González PA (2019) Herpes simplex virus evasion of early host antiviral responses. Front Cellular Infect Microbiol 9:127
doi: 10.3389/fcimb.2019.00127
-
Wells AI, Coyne CB (2018) Type Ⅲ interferons in antiviral defenses at barrier surfaces. Trends Immunol 39:848–858
doi: 10.1016/j.it.2018.08.008
-
Ye L, Schnepf D, Staeheli P (2019) Interferon-λ orchestrates innate and adaptive mucosal immune responses. Nat Rev Immunol 19:614–625
doi: 10.1038/s41577-019-0182-z
-
Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, Lewis-Antes A, Amrute SB, Garrigues U, Doyle S (2012) Type Ⅲ IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol 189:2735–2745
doi: 10.4049/jimmunol.1102038
-
Zanoni I, Granucci F, Broggi A (2017) Interferon (IFN)-λ takes the helm: immunomodulatory roles of type Ⅲ IFNs. Front Immunol 8:1661
doi: 10.3389/fimmu.2017.01661
-
Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527
doi: 10.1126/science.1139522
-
Zhang S-Q, Zhang Z, Luo X, Yang S, Chai Y, Huang H-L, Yin X-Y, Hu D-J, Yang C-J, Liu J-L (2011) Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes. Inflamm Res 60:1031
doi: 10.1007/s00011-011-0364-z
-
Zhang S-Y, Abel L, Casanova J-L (2013) Mendelian predisposition to herpes simplex encephalitis. In: Handbook of Clinical Neurology, vol 112. Elsevier, pp 1091–1097.
-
Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R (2007) Type Ⅲ interferon (IFN) induces a type Ⅰ IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81:7749–7758
doi: 10.1128/JVI.02438-06
-
Zhou L, Li J, Wang X, Ye L, Hou W, Ho J, Li H, Ho W (2011) IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons. J Neurovirol 17:212–219
doi: 10.1007/s13365-011-0031-8
-
Zhou L, Li J-L, Zhou Y, Liu J-B, Zhuang K, Gao J-F, Liu S, Sang M, Wu J-G, Ho W-Z (2015) Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells. Mhr Basic Sci Reprod Med 21:917–929
doi: 10.1093/molehr/gav058
-
Zhou Y, Wang Z, Xu Y, Zhang Z, Hua R, Liu W, Jiang C, Chen Y, Yang W, Kong W (2017) Optimized DNA vaccine enhanced by adjuvant IL28B induces protective immune responses against herpes simplex virus type 2 in mice. Viral Immunol 30:601–614
doi: 10.1089/vim.2017.0033